COYA
Price:
$4.92
Market Cap:
$89.59M
Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipeline leverages diverse approaches, including biologics designed to enhance Treg activity, Treg-derived exosomes, and personalized autologous Treg cell therapies. Among its lead candidates is COYA 101, an autologous regulatory T-cell product that has successfully completed Phase 2a clinical trials for treating Amyotrophic Lateral Sclerosis (ALS). Moving towards Investigational New Drug (IND) applications are two key candidates: COYA 301 and COYA 302. COYA 301 is a Treg-enhancing biologic aimed at tr...[Read more]
Industry
Biotechnology
IPO Date
2022-12-29
Stock Exchange
NASDAQ
Ticker
COYA
According to Coya Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.28. This represents a change of -23.22% compared to the average of -5.57 of the last 4 quarters.
The mean historical PE Ratio of Coya Therapeutics, Inc. over the last ten years is -6.78. The current -4.28 PE Ratio has changed 6.21% with respect to the historical average. Over the past ten years (40 quarters), COYA's PE Ratio was at its highest in in the December 2023 quarter at 15.44. The PE Ratio was at its lowest in in the September 2025 quarter at -10.96.
Average
-6.78
Median
-6.01
Minimum
-10.88
Maximum
-3.85
Discovering the peaks and valleys of Coya Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 143.67%
Maximum Annual PE Ratio = -3.85
Minimum Annual Increase = -43.24%
Minimum Annual PE Ratio = -10.88
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -4.57 | -21.89% |
| 2024 | -5.85 | -37.66% |
| 2023 | -9.38 | 143.67% |
| 2022 | -3.85 | -37.67% |
| 2021 | -6.18 | -43.24% |
The current PE Ratio of Coya Therapeutics, Inc. (COYA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.60
5-year avg
-5.96
10-year avg
-6.78
Coya Therapeutics, Inc.’s PE Ratio is greater than Immix Biopharma, Inc. (-9.48), less than Clene Inc. (-1.85), less than MacroGenics, Inc. (-3.75), less than Oramed Pharmaceuticals Inc. (1.44), greater than Ovid Therapeutics Inc. (-6.56), less than Context Therapeutics Inc. (-1.49), less than Pliant Therapeutics, Inc. (-0.63), less than Whitehawk Therapeutics Inc (-2.63), greater than Shattuck Labs, Inc. (-7.86), less than Zentalis Pharmaceuticals, Inc. (-2.14),
| Company | PE Ratio | Market cap |
|---|---|---|
| -9.48 | $474.38M | |
| -1.85 | $61.95M | |
| -3.75 | $262.52M | |
| 1.44 | $158.79M | |
| -6.56 | $299.38M | |
| -1.49 | $58.06M | |
| -0.63 | $71.83M | |
| -2.63 | $218.58M | |
| -7.86 | $237.12M | |
| -2.14 | $263.39M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coya Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Coya Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Coya Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Coya Therapeutics, Inc. (COYA)?
What is the highest PE Ratio for Coya Therapeutics, Inc. (COYA)?
What is the 3-year average PE Ratio for Coya Therapeutics, Inc. (COYA)?
What is the 5-year average PE Ratio for Coya Therapeutics, Inc. (COYA)?
How does the current PE Ratio for Coya Therapeutics, Inc. (COYA) compare to its historical average?